Medical Technology

@xconomy.com 3 years ago

Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms

@xconomy.com 5 years ago

After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval

@xconomy.com 5 years ago

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

@xconomy.com 5 years ago

Corza Health Emerges Led by Former NuVasive, GreatCall Executives

@xconomy.com 5 years ago

With New Cash and Facilities, Phoenix Transitions Out Of Startup Mode